AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Wang, B Norbury, CC Greenwood, R Bennink, JR Yewdell, JW Frelinger, JA
Citation: B. Wang et al., Multiple paths for activation of naive CD8(+) T cells: CD4-independent help, J IMMUNOL, 167(3), 2001, pp. 1283-1289

Authors: Prasad, SA Norbury, CC Chen, WS Bennink, JR Yewdell, JW
Citation: Sa. Prasad et al., Cutting edge: Recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells, J IMMUNOL, 166(8), 2001, pp. 4809-4812

Authors: Norbury, CC Princiotta, MF Bacik, I Brutkiewicz, RR Wood, P Elliott, T Bennink, JR Yewdell, JW
Citation: Cc. Norbury et al., Multiple antigen-specific processing pathways for activating naive CD8(+) T cells in vivo, J IMMUNOL, 166(7), 2001, pp. 4355-4362

Authors: Chen, WS Norbury, CC Cho, YJ Yewdell, JW Bennink, JR
Citation: Ws. Chen et al., Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens, J EXP MED, 193(11), 2001, pp. 1319-1326

Authors: Schubert, U Anton, LC Gibbs, J Norbury, CC Yewdell, JW Bennink, JR
Citation: U. Schubert et al., Rapid degradation of a large fraction of newly synthesized proteins by proteasomes, NATURE, 404(6779), 2000, pp. 770-774

Authors: Gretz, JE Norbury, CC Anderson, AO Proudfoot, AEI Shaw, S
Citation: Je. Gretz et al., Lymph-borne chemokines and other low molecular weight molecules reach highendothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex, J EXP MED, 192(10), 2000, pp. 1425-1439

Authors: Norbury, CC
Citation: Cc. Norbury, Tracing the route taken by peptides and major histocompatibility complex class I molecules in presentation of exogenous antigens, METH MOL B, 156, 2000, pp. 33-48

Authors: Yewdell, JW Norbury, CC Bennink, JR
Citation: Jw. Yewdell et al., Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: Implications for generating CD8(+) T cell responses to infectious agents, tumors, transplants, and vaccines, ADV IMMUNOL, 73, 1999, pp. 1-77
Risultati: 1-8 |